Skip to main content
. Author manuscript; available in PMC: 2016 Jul 6.
Published in final edited form as: JAMA Intern Med. 2015 Oct;175(10):1650–1659. doi: 10.1001/jamainternmed.2015.4095

Table 3.

Characteristics of Patients by Ryan White HIV/AIDS Program Funding Status of Outpatient HIV Health Care Facilitya

Characteristic Patients, No. (%) [95% CI]b P Value
All
(N = 8038)
RWHAP Funded
(n = 6013)
Non-RWHAP Funded
(n = 2025)
Total 6013 (72.8) [67.7–77.9] 2025 (27.2) [22.1–32.3]
Age, y
  18–29 596 (7.5) [6.7–8.4] 503 (8.5) [7.4–9.5] 93 (5.0) [3.9–6.2] <.001
  30–39 1293 (16.7) [15.5–17.9] 1026 (17.9) [16.5–19.3] 267 (13.6) [12.0–15.2]
  40–49 2940 (36.0) [34.6–37.3] 2180 (35.3) [33.7–37.0] 760 (37.8) [35.5–40.1]
  ≥50 3209 (39.8) [38.5–41.1] 2304 (38.3) [36.7–40.0] 905 (43.6) [40.6–46.6]
Sex
  Male 5764 (71.7) [69.7–73.8] 4130 (69.0) [67.0–71.0] 1634 (79.0) [75.9–82.2] <.001
  Female 2152 (26.7) [24.7–28.7] 1782 (29.2) [27.2–31.2] 370 (20.1) [17.0–23.1]
  Transgender 120 (1.5) [1.2–1.9] 99 (1.8) [1.4–2.2] 21 (0.9) [0.5–1.3]
Sexual transmission risk categoryc
  Any MSM 3733 (47.4) [44.0–50.9] 2389 (41.0) [37.5–44.6] 1344 (64.6) [60.3–68.8] <.001
  MSW only 1980 (23.6) [21.6–25.6] 1703 (27.2) [25.0–29.5] 277 (13.8) [11.8–15.8]
  Any WSM 2100 (26.0) [24.1–27.9] 1736 (28.4) [26.5–30.2] 364 (19.7) [16.7–22.8]
  Other 225 (2.9) [2.4–3.4] 185 (3.3) [2.7–4.0] 40 (1.9) [1.2–2.5]
Race/ethnicity
  White, non-Hispanic 2560 (33.5) [29.4–37.7] 1387 (25.3) [22.2–28.4] 1173 (55.6) [49.6–61.5] <.001
  Black, non-Hispanic 3316 (41.6) [35.9–47.2] 2831 (47.5) [41.5–53.5] 485 (25.8) [20.6–31.0]
  Hispanic or Latino 1775 (19.9) [15.5–24.2] 1521 (22.5) [16.4–28.6] 254 (12.9) [10.6–15.2]
  Otherd 387 (5.0) [4.2–5.8] 274 (4.8) [3.8–5.7] 113 (5.8) [4.7–6.8]
Born outside the United States 1033 (13.3) [11.6–14.9] 851 (14.7) [12.4–17.0] 182 (9.5) [7.9–11.1] .001
Educational attainment
  <High school 1824 (22.0) [20.1–23.9] 1615 (26.1) [24.0–28.3] 209 (10.9) [8.7–13.1] <.001
  High school diploma or equivalent 2206 (27.2) [25.4–29.0] 1798 (29.5) [27.6–31.4] 408 (21.1) [18.2–24.1]
  >High school 4007 (50.8) [47.8–53.7] 2599 (44.4) [41.7–47.0] 1408 (68.0) [63.5–72.4]
At or below poverty levele,f 3665 (45.4) [42.3–48.5] 3212 (53.6) [50.3–56.9] 453 (23.9) [19.7–28.0] <.001
Health insurance coverage during the past 12 moe,g
  Continuous 5768 (70.8) [67.9–73.8] 4014 (65.0) [61.8–68.1] 1754 (86.5) [84.1–88.9] <.001
  Lapsed 767 (9.3) [8.4–10.3] 620 (10.0) [8.8–11.2] 147 (7.4) [5.8–9.0]
  None 1480 (19.8) [16.9–22.8] 1358 (25.0) [21.9–28.1] 122 (6.1) [4.1–8.0]
Past 12-mo statuse
  Homeless 716 (8.5) [7.6–9.4] 626 (9.9) [8.7–11.1] 90 (4.8) [3.7–5.9] <.001
  Incarcerated 428 (5.4) [4.7–6.0] 375 (6.4) [5.6–7.2] 53 (2.7) [1.6–3.8] <.001
  Noninjection drug use 2117 (26.7) [25.1–28.2] 1518 (25.6) [23.9–27.3] 599 (29.6) [27.3–31.9] .003
  Injection drug use 215 (2.5) [1.8–3.2] 172 (2.6) [1.8–3.3] 43 (2.2) [1.3–3.2] .47
Binge alcohol use in the past 30 d 1325 (16.3) [15.4–17.3] 984 (16.1) [14.9–17.3] 341 (16.9) [15.1–18.7] .47
Time since HIV diagnosis, y
  <5 1738 (22.7) [21.5–24.0] 1392 (24.3) [22.7–25.9] 346 (18.6) [16.6–20.6] <.001
  5–9 1772 (21.8) [20.9–22.8] 1350 (22.0) [20.9–23.2] 422 (21.2) [19.2–23.2]
  ≥10 4521 (55.4) [54.0–56.9] 4240 (53.7) [51.8–55.5] 1252 (60.2) [57.6–62.9]
Disease stageh
  AIDS or nadir CD4+ 0–199 cells/µL or CD4+ <14% 5555 (68.5) [67.0–70.0] 4240 (69.7) [68.0–71.4] 1315 (65.2) [62.8–67.5] <.001
  No AIDS and nadir CD4+ 200 to 499 cells/µL or CD4+
  14% to <29%
1931 (24.9) [23.6–26.3] 1401 (24.2) [22.7–25.7] 530 (26.8) [24.5–29.1]
  No AIDS and nadir CD4+ ≥500 cells/µL or CD4+ ≥29% 516 (6.6) [5.9–7.3] 350 (6.1) [5.3–6.8] 166 (8.0) [6.9–9.2]
Depression in the past 2 wk
  Major 873 (11.1) [9.9–12.3] 669 (11.3) [10.0–12.6] 204 (10.5) [8.3–12.8] .007
  Other 964 (12.7) [11.6–13.7] 769 (13.6) [12.3–14.8] 195 (10.3) [8.7–11.9]
Prescribed ART in the past 12 moe,i 7269 (90.6) [89.5–91.7] 5423 (90.4) [89.1–91.7] 1846 (91.0) [89.4–92.6] .53
Viral suppressionj 3165 (75.5) [73.4–77.6] 2397 (74.4) [72.0–76.8] 768 (79.0) [75.9–82.2] .02

Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; MSM, men who have sex with men whether or not they also reported sex with women; MSW, men who have sex with women only; RWHAP, Ryan White HIV/AIDS Program; WSM, women who have sex with men whether or not they also reported sex with women.

a

Source of the data was the Medical Monitoring Project, 2009 and 2011.12,13

b

Data presented No. (%) are sample size (weighted percentage). Facility and patient data were weighted based on known probabilities of selection and adjusted for nonresponse using predictors of facility-level and patient-level response. The sample design and weighting methods allow inference to all outpatient HIV health care facilities providing care and HIV-infected persons receiving care in the United States during the first 4 months of the cycle year (2009 and 2011).

c

Participants who reported no anal, vaginal, or oral sex in the past 12 months were categorized according to self-reported sexual orientation.

d

Includes Asian, American Indian, Alaska native, Native Hawaiian, Other Pacific Islander, and multiracial groups.

e

During the 1-year period preceding the interview (2009 data were collected in interviews conducted between June 2009 and May 2010; 2011 data were collected in interviews conducted between June 2011 and May 2012).

f

Determined using the US Department of Health and Human Services poverty guidelines.16

g

Having health insurance or coverage does not include having only RWHAP assistance.

h

AIDS was defined as confirmed HIV infection with either: a CD4+ T-lymphocyte cell count less than 200 cells/µL, a CD4+ T-lymphocyte cell percentage of total lymphocytes less than 14%, or a diagnosis of a stage 3–defining opportunistic illness.

i

Documentation in the medical record of prescription of antiretroviral therapy.

j

Documentation in the medical record of the most recent viral load being undetectable or less than 200 copies/mL.